BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17665327)

  • 21. Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes.
    Rupnik M
    FEMS Microbiol Rev; 2008 May; 32(3):541-55. PubMed ID: 18397287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outbreak from a high-toxin intruder: Clostridium difficile.
    Norén T
    Lancet; 2005 Sep 24-30; 366(9491):1053-4. PubMed ID: 16182878
    [No Abstract]   [Full Text] [Related]  

  • 23. Bacteremia with a large clostridial toxin-negative, binary toxin-positive strain of Clostridium difficile.
    Elliott B; Reed R; Chang BJ; Riley TV
    Anaerobe; 2009 Dec; 15(6):249-51. PubMed ID: 19723585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathogenicity of Clostridium difficile.
    Poxton IR; McCoubrey J; Blair G
    Clin Microbiol Infect; 2001 Aug; 7(8):421-7. PubMed ID: 11591205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PROBIOTICS FOR THE PREVENTION OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA IN ADULTS AND CHILDREN.
    Gaines C; Moore J
    Gastroenterol Nurs; 2019; 42(3):299-301. PubMed ID: 31145259
    [No Abstract]   [Full Text] [Related]  

  • 26. Collateral damage. The rise of resistant C. difficile.
    Taubes G
    Science; 2008 Jul; 321(5887):360. PubMed ID: 18635789
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates.
    Akerlund T; Svenungsson B; Lagergren A; Burman LG
    J Clin Microbiol; 2006 Feb; 44(2):353-8. PubMed ID: 16455883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of toxins A and B in the pathogenesis of Clostridium difficile disease.
    Bongaerts GP; Lyerly DM
    Microb Pathog; 1994 Jul; 17(1):1-12. PubMed ID: 7861949
    [No Abstract]   [Full Text] [Related]  

  • 29. Epidemic Clostridium difficile strain in hospital visitation dog.
    Lefebvre SL; Arroyo LG; Weese JS
    Emerg Infect Dis; 2006 Jun; 12(6):1036-7. PubMed ID: 16752477
    [No Abstract]   [Full Text] [Related]  

  • 30. TcdB or not TcdB: a tale of two Clostridium difficile toxins.
    Carter GP; Awad MM; Kelly ML; Rood JI; Lyras D
    Future Microbiol; 2011 Feb; 6(2):121-3. PubMed ID: 21366410
    [No Abstract]   [Full Text] [Related]  

  • 31. Reining in recurrent Clostridium difficile infection--who's at risk?
    Surawicz CM
    Gastroenterology; 2009 Apr; 136(4):1152-4. PubMed ID: 19250653
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of toxemia in patients with Clostridium difficile infection.
    Yu H; Chen K; Wu J; Yang Z; Shi L; Barlow LL; Aronoff DM; Garey KW; Savidge TC; von Rosenvinge EC; Kelly CP; Feng H
    PLoS One; 2015; 10(4):e0124235. PubMed ID: 25885671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bezlotoxumab (Zinplava) for prevention of recurrent Clostridium difficile infection.
    Med Lett Drugs Ther; 2017 Mar; 59(1517):49-50. PubMed ID: 28323808
    [No Abstract]   [Full Text] [Related]  

  • 34. Infection with Toxin A-Negative, Toxin B-Negative, Binary Toxin-Positive Clostridium difficile in a Young Patient with Ulcerative Colitis.
    Androga GO; Hart J; Foster NF; Charles A; Forbes D; Riley TV
    J Clin Microbiol; 2015 Nov; 53(11):3702-4. PubMed ID: 26354812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary.
    Terhes G; Urbán E; Sóki J; Szikra L; Konkoly-Thege M; Vollain M; Nagy E
    Anaerobe; 2009 Dec; 15(6):237-40. PubMed ID: 19682411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeat Clostridium difficile Testing.
    Gupta A; Khanna S
    JAMA; 2016 Dec; 316(22):2422-2423. PubMed ID: 27959982
    [No Abstract]   [Full Text] [Related]  

  • 37. Clostridium difficile colitis: pathogenesis and host defence.
    Abt MC; McKenney PT; Pamer EG
    Nat Rev Microbiol; 2016 Oct; 14(10):609-20. PubMed ID: 27573580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dramatic increase of Clostridium difficile-associated diarrhea in Germany: has the new strain PCR-ribotype 027 already reached us?].
    Reichardt C; Chaberny IF; Kola A; Mattner F; Vonberg RP; Gastmeier P
    Dtsch Med Wochenschr; 2007 Feb; 132(5):223-8. PubMed ID: 17252365
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of toxin A negative/B positive Clostridium difficile strains.
    Brazier JS; Stubbs SL; Duerden BI
    J Hosp Infect; 1999 Jul; 42(3):248-9. PubMed ID: 10440000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.